Telomerase Beats Gold Standard Biomarkers CA 19-9, CEA, and Mayo Formula-Differentiates Cholangiocarcinoma from Benign Bile Ducts Ȁ It Can Be Done with ERCP Ȁ A Major Clinical Diagnostic Advancement